|
10313
|
1
|
Clearing the Air on Behavioral Health Conditions and Tobacco Use
|
|
10316
|
1
|
Vapes, Pouches and IQOS: The Latest and Greatest Tobacco Products?
|
|
10318
|
1
|
Current landscape of tobacco pharmacotherapy What clinicians need to know about current FDA-approved medications and those seeking approval.
|
|
10319
|
1
|
Co-treatment in Youth
|
|
10322
|
1
|
Vaping: Health Effects, Treatment Strategies, and Clinical Implications
|
|
10323
|
1
|
MI Pearls: practical tips and how to use Motivational Interviewing across different cultures.
|
|
10325
|
1
|
Behind the Scan: The Tobacco Treatment Specialist's role in lung cancer screening and roadblocks with insurance coverage.
|
|
10326
|
1
|
Ethics in Healthecare Beyond the Bedside Series
|
|
10327
|
1
|
Enhancing Patients' Adherence and Engagement in Treatment
|
|
10328
|
1
|
Understanding and Managing Postpartum Psychosis
|
|
10332
|
1
|
Conversion Therapy: Unraveling Its History and Harm
|
|
10335
|
1
|
Bridging Guidelines and Practice: CSA Management in Todays Sleep Lab
|
|
10337
|
1
|
Best Management Practices in Somatic Symptom Disorder
|
|
10338
|
1.25
|
The Little Plant that Kills: Nicotine Dependence and Other Substance Use Disorders
|
|
10339
|
4
|
C1 Hamilton Vent and BiPaP
|
|
10340
|
0.5
|
Lessons Learned from Memorial Sloan Kettering Cancer Center's Tobacco Treatment Training in Oncology
|
|
10341
|
5
|
Safety Strong
|
|
10342
|
0.5
|
The Multisystemic Therapy (MST) Approach in Youth's Tobacco Recovery
|
|
10343
|
1
|
Still ON the ObsessZYN
|
|
10344
|
1
|
Vaping: Health Effects, Flavoring & the NDQYT ACCESs Study
|
|
10345
|
0.5
|
Fargo Youth Voices: The Intersection of Prevention Policy & Treatment
|
|
10346
|
1.5
|
Partnering with Pharmacists to Enhance Tobacco & Nicotine Treatment in North Dakota: Practical Strategies for Clinical Teams
|
|
10347
|
1
|
NDSRC: State of the Society
|
